SB-318
SB-318-1502
Phase 2 mab terminated
Quick answer
SB-318 for MPS I is a Phase 2 program (mab) at SANGAMO THERAPEUTICS, INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SANGAMO THERAPEUTICS, INC
- Indication
- MPS I
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated